provider. The Advocates for Responsible Care was then established to advocate on behalf of the patients’ right to receive continuous treatment. At this time we first issued a Letter to the Grady Board of Directors followed by our Statement to the Grady Board of Directors . Our action was especially pertinent given that the patients are dependent upon dialysis treatment three times a week for their survival.
contracted with a private company, Fresenius, to provide dialysis treatment at their local centers. Multiple times Grady attempted to prematurely terminate their contract with Fresenius, but, thanks to the steadfast efforts of ARxC, Grady eventually allowed the contract to fulfill its year-long duration.
13 randomly selected patients would receive ‘in kind’ treatment from Emory Dialysis, Fresenius, and DaVita. The remaining 25 patients would be provided dialysis treatment for one year through a contract between Grady Hospital and Fresenius. Part of this contract requires that the patients pay a monthly fee for their dialysis care (see September 14, 2010 Press Release).At this time none of ARxC’s patients have received a written statement verifying that their dialysis will be continued by a specified dialysis provider. However, to date, all of the patients have continued to receive their routine dialysis treatments. We expect their care to continue until September 1, 2011.

We believe that this is a crisis of honoring human life. This is the reason why we have appealed to the Human Rights Commission to help us find sustainable dialysis for these patients.
Please post your comments on the Contact Us page. We welcome your input on this issue as we have yet to find a solution that ensure the remaining 30 patients will receive long-term dialysis treatment after the August 31, 2010 deadline.
As a 501(c)3 non-profit organization we rely on donations to continue our work as patient advocates. Please consider making a donation to further our efforts by going to our Please Donate webpage.